Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bylvay
Bylvay
After Albireo buyout, Ipsen's Bylvay picks up new FDA-approved use
Fierce Pharma
Wed, 06/14/23 - 10:22 am
Ipsen
Bylvay
Albireo Pharma
M&A
FDA
liver disease
Bluebird’s new gene therapy among three new EMA OKs ahead of FDA
Endpoints
Fri, 05/21/21 - 10:56 am
gene therapy
Bluebird Bio
EMA
GSK
Vir
COVID-19
Skysona
monoclonal antibodies
Bylvay